C86.60 Primary cutaneous CD30-positive T-cell proliferations not having achieved remission

Instructional Notes:

C86.60
Description: Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
Inclusion Term:
- Lymphomatoid papulosis NOS
- Lymphomatoid papulosis not having achieved remission
- Lymphomatoid papulosis with failed remission
- Primary cutaneous anaplastic large cell lymphoma NOS
- Primary cutaneous anaplastic large cell lymphoma not having achieved remission
- Primary cutaneous anaplastic large cell lymphoma with failed remission
- Primary cutaneous CD30-positive large T-cell lymphoma NOS
- Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
- Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
- Primary cutaneous CD30-positive T-cell proliferations NOS
- Primary cutaneous CD30-positive T-cell proliferations with failed remission
↓
C86.6
Description: Primary cutaneous CD30-positive T-cell proliferations
Inclusion Term:
- Lymphomatoid papulosis
- Primary cutaneous anaplastic large cell lymphoma
- Primary cutaneous CD30-positive large T-cell lymphoma
↓
C86
Description: Other specified types of T/NK-cell lymphoma
Exclude1:
- anaplastic large cell lymphoma, ALK negative (C84.7-)
- anaplastic large cell lymphoma, ALK positive (C84.6-)
- mature T/NK-cell lymphomas (C84.-)
- other specified types of non-Hodgkin lymphoma (C85.8-)
↓
C81-C96
Description: Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
Exclude2:
- Kaposi's sarcoma of lymph nodes (C46.3)
- secondary and unspecified neoplasm of lymph nodes (C77.-)
- secondary neoplasm of bone marrow (C79.52)
- secondary neoplasm of spleen (C78.89)
↓
C00-D49
Description: Neoplasms
Notes:
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).